Log in to save to my catalogue

Metastatic insulinoma-outcomes in the current era

Metastatic insulinoma-outcomes in the current era

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3122635777

Metastatic insulinoma-outcomes in the current era

About this item

Full title

Metastatic insulinoma-outcomes in the current era

Publisher

England: Oxford University Press

Journal title

The oncologist (Dayton, Ohio), 2024-10, Vol.30 (3)

Language

English

Formats

Publication information

Publisher

England: Oxford University Press

More information

Scope and Contents

Contents

Multimodal interventions in neuroendocrine tumors appear to have a beneficial impact on survival. Metastatic insulinoma is associated with hypoglycemia and, historically, a shortened life expectancy.
The authors retrospectively analyzed the clinical outcomes of patients with metastatic insulinomas treated at a tertiary care center between 2006 a...

Alternative Titles

Full title

Metastatic insulinoma-outcomes in the current era

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3122635777

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3122635777

Other Identifiers

ISSN

1083-7159,1549-490X

E-ISSN

1549-490X

DOI

10.1093/oncolo/oyae275

How to access this item